Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas.

Nascimento EJM, Bonaparte MI, Luo P, Vincent TS, Hu B, George JK, Áñez G, Noriega F, Zheng L, Huleatt JW.

Am J Trop Med Hyg. 2019 Aug 5. doi: 10.4269/ajtmh.19-0270. [Epub ahead of print]

PMID:
31392955
2.

Development of antibody biomarkers of long term and recent dengue virus infections.

Nascimento EJM, Huleatt JW, Cordeiro MT, Castanha PMS, George JK, Grebe E, Welte A, Brown M, Burke DS, Marques ETA.

J Virol Methods. 2018 Jul;257:62-68. doi: 10.1016/j.jviromet.2018.04.009. Epub 2018 Apr 21.

3.

Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus.

Nascimento EJM, George JK, Velasco M, Bonaparte MI, Zheng L, DiazGranados CA, Marques ETA, Huleatt JW.

J Virol Methods. 2018 Jul;257:48-57. doi: 10.1016/j.jviromet.2018.03.007. Epub 2018 Mar 19.

4.

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.

Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, Jacobs A, Tang J, McDonald W, Song L, Evans RK, Umlauf S, Tussey L, Powell TJ.

Vaccine. 2008 Jan 10;26(2):201-14. Epub 2007 Nov 20.

PMID:
18063235
5.

A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.

McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, Price A, Jacobs A, Takahashi VN, Huang Y, Nakaar V, Alexopoulou L, Fikrig E, Powell TJ.

J Infect Dis. 2007 Jun 1;195(11):1607-17. Epub 2007 Apr 17.

PMID:
17471430
6.

Expression and function of synaptotagmin VII in CTLs.

Fowler KT, Andrews NW, Huleatt JW.

J Immunol. 2007 Feb 1;178(3):1498-504.

7.

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.

Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, Huang Y, Song L, Nakaar V, Powell TJ.

Vaccine. 2007 Jan 8;25(4):763-75. Epub 2006 Aug 22.

PMID:
16968658
8.

MyD88-dependent induction of allergic Th2 responses to intranasal antigen.

Piggott DA, Eisenbarth SC, Xu L, Constant SL, Huleatt JW, Herrick CA, Bottomly K.

J Clin Invest. 2005 Feb;115(2):459-67.

9.
10.
11.

Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen.

Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K.

J Exp Med. 2002 Dec 16;196(12):1645-51.

12.
13.

Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle.

Dao T, Huleatt JW, Hingorani R, Crispe IN.

J Immunol. 1997 Nov 1;159(9):4261-7.

PMID:
9379021
14.

On the front lines: intraepithelial lymphocytes as primary effectors of intestinal immunity.

Lefrançois L, Fuller B, Huleatt JW, Olson S, Puddington L.

Springer Semin Immunopathol. 1997;18(4):463-75. Review. No abstract available.

PMID:
9144865
15.
16.

Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo.

Huleatt JW, Lefrançois L.

J Immunol. 1995 Jun 1;154(11):5684-93.

PMID:
7751620
17.

Regulation of MHC class I synthesis and expression by human neutrophils.

Neuman E, Huleatt JW, Vargas H, Rupp EE, Jack RM.

J Immunol. 1992 Jun 1;148(11):3520-7.

PMID:
1534098
18.

Supplemental Content

Loading ...
Support Center